Hydroxychloroquine cardiac scare ‘debunked’

The study in patients with rheumatoid arthritis and lupus finds no association with prolonged QT interval
Medicom Staff writer

AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.

Patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) who take hydroxychloroquine do not appear to have longer corrected QT intervals (QTc) than others who are not on the drug, US researchers say.